Section Gerontology and Geriatrics, Department of Internal Medicine, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.
Department of Geriatrics, Catharina Hospital, Eindhoven, The Netherlands.
Eur Geriatr Med. 2024 Aug;15(4):941-949. doi: 10.1007/s41999-024-01002-0. Epub 2024 Jun 11.
The aim of the present study was to investigate characteristics and outcomes in vaccinated and unvaccinated older patients hospitalized for COVID-19 infection.
A retrospective multicentre cohort study among patients aged ≥70 years hospitalized for COVID-19 infection.
263 vaccinated and 82 unvaccinated patients were included. Vaccinated patients were older (median age 79 vs. 76 years; p < 0.001), more patients were male (66.2% vs. 53.7%; p = 0.040), had more comorbidities [median Charlson Comorbidity Index (CCI) 2 vs. 1; p 0.016] and were frailer [Clinical Frailty Scale (CFS) ≥ 4 68% vs. 49%; p 0.015]. Vaccinated patients were admitted earlier after symptom onset (median 5 days vs. 7 days) but were equally ill at time of hospital admission. After correction for frailty, comorbidity and disease severity, risk of in-hospital mortality was three times lower for vaccinated patients (HR 0.30 95% CI 0.16-0.56; p < 0.001) compared to unvaccinated patients.
Vaccinated patients had lower risk of in-hospital mortality than unvaccinated patients with COVID-19 infection. These findings suggest that vaccinated patients benefit from the protective effect of the vaccine against death during hospital stay, outweighing the increased mortality risk that is associated with older age, greater frailty and more numerous comorbidities. This could be an encouragement for older people to receive age-appropriate vaccines, although no definite conclusions can be drawn for this was no intervention study.
本研究旨在探讨接种疫苗和未接种疫苗的老年 COVID-19 感染住院患者的特征和结局。
一项回顾性多中心队列研究,纳入年龄≥70 岁因 COVID-19 感染住院的患者。
纳入 263 名接种疫苗和 82 名未接种疫苗的患者。接种疫苗的患者年龄更大(中位数年龄 79 岁 vs. 76 岁;p<0.001),更多患者为男性(66.2% vs. 53.7%;p=0.040),合并症更多[中位数 Charlson 合并症指数(CCI)2 分 vs. 1 分;p<0.016]且更虚弱[临床虚弱量表(CFS)≥4 分 68% vs. 49%;p<0.015]。接种疫苗的患者在症状出现后更早入院(中位数 5 天 vs. 7 天),但入院时疾病严重程度相同。在调整虚弱、合并症和疾病严重程度后,与未接种疫苗的患者相比,接种疫苗的患者住院期间死亡风险降低了三倍(HR 0.30,95%CI 0.16-0.56;p<0.001)。
与未接种 COVID-19 疫苗的患者相比,接种疫苗的患者住院期间死亡风险更低。这些发现表明,接种疫苗的患者受益于疫苗对住院期间死亡的保护作用,超过了与年龄较大、更虚弱和更多合并症相关的更高死亡风险。这可能鼓励老年人接种适合年龄的疫苗,尽管由于这不是一项干预研究,因此不能得出明确的结论。